OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
Luigi Gargiulo, Luciano Ibba, Carlo Alberto Vignoli, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 9
Luigi Gargiulo, Luciano Ibba, Carlo Alberto Vignoli, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
Carlo Alberto Vignoli, Luigi Gargiulo, Luciano Ibba, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access | Times Cited: 2
Carlo Alberto Vignoli, Luigi Gargiulo, Luciano Ibba, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access | Times Cited: 2
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review
Luciano Ibba, Luigi Gargiulo, Carlo Alberto Vignoli, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 593-604
Open Access | Times Cited: 8
Luciano Ibba, Luigi Gargiulo, Carlo Alberto Vignoli, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 593-604
Open Access | Times Cited: 8
Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients
Takafumi Numata, Ryokichi Irisawa, Miho Mori, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv18348-adv18348
Open Access | Times Cited: 6
Takafumi Numata, Ryokichi Irisawa, Miho Mori, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv18348-adv18348
Open Access | Times Cited: 6
Effectiveness and Safety of Baricitinib in Patients with Severe Alopecia Areata in Yamaguchi University Hospital
Takuya KURISU, Yutaka Shimomura
The Nishinihon Journal of Dermatology (2025) Vol. 87, Iss. 1, pp. 64-68
Closed Access
Takuya KURISU, Yutaka Shimomura
The Nishinihon Journal of Dermatology (2025) Vol. 87, Iss. 1, pp. 64-68
Closed Access
Safety Profile of Baricitinib in Patients With Severe Alopecia Areata: A Prospective Study
Isotta Giunipero di Corteranzo, Eleonora Bongiovanni, Stephano Cedirian, et al.
International Journal of Dermatology (2025)
Closed Access
Isotta Giunipero di Corteranzo, Eleonora Bongiovanni, Stephano Cedirian, et al.
International Journal of Dermatology (2025)
Closed Access
Real‐life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study
A Mourtada, C. Douarec, Matthieu Wargny, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
A Mourtada, C. Douarec, Matthieu Wargny, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center
Moyuka Wada‐Irimada, Takehiro Takahashi, Mana Sekine, et al.
The Journal of Dermatology (2025)
Closed Access
Moyuka Wada‐Irimada, Takehiro Takahashi, Mana Sekine, et al.
The Journal of Dermatology (2025)
Closed Access
Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
Giacomo Caldarola, Lorenzo Maria Pinto, Francesco Bellinato, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 11, pp. 1483-1487
Closed Access
Giacomo Caldarola, Lorenzo Maria Pinto, Francesco Bellinato, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 11, pp. 1483-1487
Closed Access
